Back to Journals » Drug Design, Development and Therapy » Volume 9
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
12,813 | Dovepress* | 11,523+ | 1,758 | 13,281 | |
PubMed Central* | 1,290 | 496 | 1,786 | ||
Totals | 12,813 | 2,254 | 15,067 | ||
*Since 16 March 2015 +Since July 2016 |
View citations on PubMed Central and Google Scholar